Journal article

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry

Letitia D Smith, Andrea A Tesoriero, Ee M Wong, Susan J Ramus, Frances P O'Malley, Anna Marie Mulligan, Mary Beth Terry, Ruby T Senie, Regina M Santella, Esther M John, Irene L Andrulis, Hilmi Ozcelik, Mary B Daly, Andrew K Godwin, Saundra S Buys, Stephen Fox, David E Goldgar, Graham G Giles, John L Hopper, Melissa C Southey

Breast Cancer Research | BIOMED CENTRAL LTD | Published : 2011

Grants

Awarded by National Cancer Institute, National Institutes of Health through Breast Cancer Family Registry (BCFR)


Awarded by National Cancer Institute, National Institutes of Health through Cancer Care Ontario


Awarded by Columbia University


Awarded by Fox Chase Cancer Center


Awarded by Huntsman Cancer Institute


Awarded by Northern California Cancer Center


Awarded by University of Melbourne


Awarded by Research Triangle Institute Informatics Support Center


Funding Acknowledgements

This work was supported by the National Cancer Institute, National Institutes of Health, under RFA-CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario (grant U01 CA69467), Columbia University (grant U01 CA69398), Fox Chase Cancer Center (grant U01 CA69631), Huntsman Cancer Institute (grant U01 CA69446), Northern California Cancer Center (grant U01 CA69417), University of Melbourne (grant U01 CA69638) and Research Triangle Institute Informatics Support Center (RFP N02PC45022-46). The content of this article does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating BCFR centers, nor does the mention of trade names, commercial products or organizations imply endorsement by the U.S. government or the BCFR. JLH is a National Health and Medical Research (NHMRC) Australia Fellow and Victorian Breast Cancer Consortium Group Leader, and MCS is a NHMRC Senior Research Fellow and Victorian Breast Cancer Consortium Group Leader. Multiplex Ligation-dependent Probe Amplification fragments were analysed by the Australian Genome Research Facility (AGRF), Melbourne, Australia. AGRF is funded by the Commonwealth of Australia.